Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Work In Process (2018 - 2019)

Niagen Bioscience (NAGE) has disclosed Work In Process for 2 consecutive years, with $4.7 million as the latest value for Q4 2019.

  • On a quarterly basis, Work In Process rose 66.75% to $4.7 million in Q4 2019 year-over-year; TTM through Dec 2019 was $4.7 million, a 66.75% increase, with the full-year FY2019 number at $4.7 million, up 66.75% from a year prior.
  • Work In Process was $4.7 million for Q4 2019 at Niagen Bioscience, up from $2.8 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $4.7 million in Q4 2019 to a low of $2.8 million in Q4 2018.